Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
Recruiting now
Conditions studied: Amblyopia, Strabismus
In brief
Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.
Key facts
- Study ID
- NCT04310241
- Run by
- The Cleveland Clinic
- People needed
- 150
- Starts
- 2020-02-21
- Expected to finish
- 2027-03-12
- Last updated by the study team
- 2026-03-04
Who can join
Age: 1 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- History of amblyopia or presence of amblyogenic risk factors.
You may not qualify if…
- History of neurologic disorders
Where it is running
- Cleveland Clinic — Cleveland, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.